Cover Image

Efficacy of small molecules against the severe acute respiratory syndrome coronavirus 2 XBB1.16 and XBB1.9.2.1

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Lunzhi Yuan, Xuan Liu, Song Li, Wu Zhong, Ningshao Xia
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	MedComm
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

XBB.1.16‐RBD‐based trimeric protein vaccine can effectively inhibit XBB.1.16‐included XBB subvariant infection
by: Dandan Peng, et al.
Published: (2024)

Chronic hepatitis B virus infection deteriorates disease outcome of coronavirus disease 2019 in hamster
by: Lunzhi Yuan, et al.
Published: (2024)

Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
by: Ming Zhou, et al.
Published: (2025)

Decisive reversal of lethal coronavirus disease 2019 in senescent hamster by synchronic antiviral and immunoregulatory intervention
by: Xuan Liu, et al.
Published: (2024)

Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
by: Puja Jaishwal, et al.
Published: (2024)

Chemoproteomics enables identification of coatomer subunit zeta‐1 targeted by a small molecule for enterovirus A71 inhibition
by: Xiaoyong Li, et al.
Published: (2024)

Airway epithelial‐derived exosomes induce acute asthma exacerbation after respiratory syncytial virus infection
by: Ye Yao, et al.
Published: (2024)

Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
by: Minjin Wang, et al.
Published: (2024)

Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies
by: Rongli Xie, et al.
Published: (2025)

A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter
by: Qian Ding, et al.
Published: (2024)

Vaccine and therapeutic agents against the respiratory syncytial virus: resolved and unresolved issue
by: Qianqian Li, et al.
Published: (2024)

KSQ‐4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1‐Mediated Multidrug Resistant Cancers
by: Qihong Yang, et al.
Published: (2025)

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy
by: Junyu Wang, et al.
Published: (2024)

PPP2R1A Mutation: A Critical Amplifier for Immune Checkpoint Blockade Therapy Efficacy
by: Yuanzhuo Gu, et al.
Published: (2025)

Butyrolactone I blocks the transition of acute kidney injury to chronic kidney disease in mice by targeting JAK1
by: Zijun Zhang, et al.
Published: (2025)

Improvement of the Anticancer Efficacy of PD‐1/PD‐L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies
by: Peng Gao, et al.
Published: (2025)

Development of potent pan‐coronavirus fusion inhibitors with a new design strategy
by: Yuanmei Zhu, et al.
Published: (2024)

The ischemia‐enhanced myocardial infarction protection‐related lncRNA protects against acute myocardial infarction
by: Rongzhou Wu, et al.
Published: (2024)

Overexpression of PRDM16 attenuates acute kidney injury progression: genetic and pharmacological approaches
by: Xiaozhou Li, et al.
Published: (2024)

SIRT1 Alleviates Mitochondrial Fission and Necroptosis in Cerebral Ischemia/Reperfusion Injury via SIRT1–RIP1 Signaling Pathway
by: Xuan Wei, et al.
Published: (2025)

Perioperative immunotherapy: the main clinical treatment for resectable non‐small cell lung cancer
by: Zhijun Yuan, et al.
Published: (2024)

Insulin‐Like Growth Factor 2 mRNA Binding Protein 2 Promotes HBV‐Associated Hepatocellular Carcinoma Progression by Enhancing Heme Oxygenase 1 Stability in an M 6 A‐dependent Manner
by: Yan Zhao, et al.
Published: (2025)

Yin Yang 1 Promotes Antiprogrammed Cell Death‐1 Resistance in Hepatocellular Carcinoma through Polypeptide N‐Acetylgalactosaminyltransferase 16‐Mediated Glycosylation of Programmed Death Ligand‐1
by: Shu‐sheng Lin, et al.
Published: (2025)

NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
by: Jiwei Zhang, et al.
Published: (2024)

Serotonin signaling: a new player and therapeutic target beyond Long‐haul coronavirus disease
by: Lan Bai, et al.
Published: (2024)

NDUFS1‐Mediated Mitochondrial Complex I Activity Maintains Pancreatic Cancer Stemness by Promoting PAX2 Hypomethylation
by: Xin‐Yu Fan, et al.
Published: (2026)

SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis
by: Chen Tang, et al.
Published: (2025)

Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross‐Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses
by: Ximeng Ma, et al.
Published: (2025)

Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy
by: Ram Abou Zaki, et al.
Published: (2025)

Enhancing the effectiveness of anti‐respiratory virus vaccines by bolstering mucosal immunity and cellular defenses
by: Rubing Xue, et al.
Published: (2024)

Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
by: Heng Liang, et al.
Published: (2024)

Vitamin B12 protects necrosis of acinar cells in pancreatic tissues with acute pancreatitis
by: Yulin Chen, et al.
Published: (2024)

CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
by: Zitong Zhao, et al.
Published: (2024)

Cannabidiol restores hematopoietic stem cell stemness in mouse through Atf2–Lrp6 axis after acute irradiation
by: Zhijie Bai, et al.
Published: (2025)

Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
by: Yaqing Liu, et al.
Published: (2025)

HCoV‐HKU1 and TMPRSS2 interaction: uncovering mechanisms of viral invasion
by: Zehan Pang, et al.
Published: (2025)

Structural basis of neuropeptide Y signaling through Y1 and Y2 receptors
by: Siyuan Shen, et al.
Published: (2024)

Blood Microbiome Reveals the Impact of Lactobacillus on the Efficacy of Immunotherapy in Gastrointestinal Cancer
by: Ya‐Shang Zheng, et al.
Published: (2025)

Efficacy of Disitamab Vedotin and Immune Profiles in High‐Risk Non‐Muscle‐Invasive Bladder Cancer With HER2 Overexpression
by: Haoyang Liu, et al.
Published: (2025)

Phase 1b trial of anti‐HER2 antibody inetetamab and pan‐HER inhibitor pyrotinib in HER2‐positive advanced lung cancer
by: Yihua Huang, et al.
Published: (2024)